AACR Annual Meeting 2018: Using Precision Medicine to Target RET-altered Cancers
While immunotherapy may be the latest tool in the treatment armamentarium for cancer, many ongoing clinical trials are assessing...
Tag: Precision medicine
While immunotherapy may be the latest tool in the treatment armamentarium for cancer, many ongoing clinical trials are assessing...
Hot on the heels of the FDA’s landmark approval of an anticancer therapeutic for use based on whether a...
Experts identify opportunities and challenges facing cancer researchers in 2017.
SABCS is a comprehensive scientific meeting that provides the latest information on prevention, diagnosis, and treatment of breast cancer...
On March 7, the AACR co-hosted its first, local advocacy event with the Moffitt Cancer Center in Tampa, Florida....
We asked experts in cancer precision medicine, immunotherapy, and prevention what breakthroughs we might expect to see in 2016...
Editor’s Note: Several prominent American Association for Cancer Research (AACR) leaders have shared their reactions to President Obama’s Jan....
The American Association for Cancer Research (AACR) applauds and commends President Obama and Vice President Biden for their dedication...
Guest Post by Scott M. Lippman, MD UC San Diego Moores Cancer Center
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the lung cancer community during...